Resultados de procura - Elliot Stieglitz
- Mostrando 1 - 16 Resultados de 16
-
1
Genetic predispositions to childhood leukemia por Elliot Stieglitz, Mignon L. Loh
Publicado 2013Artigo -
2
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia por Elliot Stieglitz, Tali Mazor, Adam B. Olshen, Huimin Geng, Laura C Gelston, Jon Akutagawa, Daniel B. Lipka, Christoph Plass, Christian Flotho, Farid Chehab, Benjamin S. Braun, J Costello, Mignon L. Loh
Publicado 2017Artigo -
3
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia por Maximilian Schönung, Julia Meyer, Peter Nöllke, Adam B. Olshen, Mark Hartmann, Norihiro Murakami, Manabu Wakamatsu, Yusuke Okuno, Christoph Plass, Mignon L. Loh, Charlotte M. Niemeyer, Hideki Muramatsu, Christian Flotho, Elliot Stieglitz, Daniel B. Lipka
Publicado 2020Artigo -
4
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group por Elliot Stieglitz, Ashley F. Ward, Robert B. Gerbing, Todd A. Alonzo, R.J. Arceci, Y. Lucy Liu, Peter D. Emanuel, Brigitte C. Widemann, Jennifer W. Cheng, Nalini Jayaprakash, Frank M. Balis, Robert P. Castleberry, Nancy Bunin, Mignon L. Loh, Todd M. Cooper
Publicado 2014Artigo -
5
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia por Elliot Stieglitz, Camille Troup, Laura C Gelston, John Haliburton, Eric D. Chow, Kristie B. Yu, Jon Akutagawa, Amaro Taylor‐Weiner, Y. Lucy Liu, Yong‐Dong Wang, Kyle Beckman, Peter D. Emanuel, Benjamin S. Braun, Adam R. Abate, Robert B. Gerbing, Todd A. Alonzo, Mignon L. Loh
Publicado 2014Artigo -
6
Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>–Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALL por Matthew A. Nix, Kamal Mandal, Huimin Geng, Neha Paranjape, Yu-Hsiu T. Lin, José M. Rivera, Makeba Marcoulis, Kristie L. White, Jeffrey D. Whitman, Sagar P. Bapat, Kevin R. Parker, Jonathan Ramírez, Anne Deucher, Paul Phojanokong, Veronica Steri, Faranak Fattahi, Byron Hann, Ansuman T. Satpathy, Aashish Manglik, Elliot Stieglitz, Arun P. Wiita
Publicado 2021Artigo -
7
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML por Akihide Yoshimi, Maria E. Balasis, Alexis Vedder, Kira Feldman, Yan Ma, Hailing Zhang, Stanley Chun-Wei Lee, Christopher T. Letson, Sandrine Niyongere, Sydney X. Lu, Markus Ball, Justin Taylor, Qing Zhang, YuLong Zhao, Salma Youssef, Young Rock Chung, Xiao Jing Zhang, Benjamin H. Durham, Wendy Yang, Alan F. List, Mignon L. Loh, Virginia M. Klimek, Michael F. Berger, Elliot Stieglitz, Eric Padron, Omar Abdel‐Wahab
Publicado 2017Artigo -
8
Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome por Yline Capri, Elisabetta Flex, Oliver H.F. Krumbach, Giovanna Carpentieri, Serena Cecchetti, Christina Lißewski, Soheila Rezaei Adariani, Denny Schanze, Julia Brinkmann, Juliette Piard, Francesca Pantaleoni, Francesca Romana Lepri, Elaine Goh, Karen Chong, Elliot Stieglitz, Julia Meyer, Alma Kuechler, Nuria C. Bramswig, Stephanie Sacharow, Marion Strullu, Yoann Vial, Cédric Vignal, George Kensah, Goran Čuturilo, Neda S. Kazemein Jasemi, Radovan Dvorský, Kristin G. Monaghan, Lisa M. Vincent, Hélène Cavé, Alain Verloès, Mohammad Reza Ahmadian, Marco Tartaglia, Martin Zenker
Publicado 2019Artigo -
9
International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant por Alexandra S. Whale, Alison S. Devonshire, George Karlin‐Neumann, Jack Regan, Leanne Javier, Simon Cowen, Ana Fernández-González, Gerwyn M. Jones, Nicholas Redshaw, Julia Beck, Andreas W. Berger, Valérie Combaret, Nina Dahl Kjersgaard, Lisa M. Davis, Frédéric Fina, Tim Forshew, Rikke Fredslund Andersen, Silvia Galbiati, Álvaro González Hernández, Charles A. Haynes, Filip Janků, Roger Lacave, Justin Lee, Vilas Mistry, Alexandra Pender, Anne Pradines, Charlotte Proudhon, Lao H. Saal, Elliot Stieglitz, Bryan C. Ulrich, Carole A. Foy, Helen Parkes, Svilen Tzonev, Jim F. Huggett
Publicado 2016Artigo -
10
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus por Peter de Blank, Andrea M. Gross, Srivandana Akshintala, Jaishri O. Blakeley, Gideon Bollag, Ashley Cannon, Eva Dombi, Jason Fangusaro, Bruce D. Gelb, Darren Hargrave, AeRang Kim, Laura J. Klesse, Mignon L. Loh, Staci Martin, Christopher L. Moertel, Roger J. Packer, Jonathan M. Payne, Katherine A. Rauen, Jonathan J. Rios, Nathan Robison, Elizabeth K. Schorry, Kevin Shannon, David A. Stevenson, Elliot Stieglitz, Nicole J. Ullrich, Karin S. Walsh, Brian Weiss, Pamela L. Wolters, Kaleb Yohay, Marielle E. Yohe, Brigitte C. Widemann, Michael J. Fisher
Publicado 2022Revisão -
11
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target por Kamal Mandal, Gianina Wicaksono, Clinton Yu, Jarrett Adams, Michael R. Hoopmann, William C. Temple, Adila Izgutdina, Bonell Patiño-Escobar, Maryna Gorelik, Christian Ihling, Matthew A. Nix, Akul Naik, William Xie, Juwita Hübner, Lisa Rollins, S. Reid, Emilio Ramos, Corynn Kasap, Veronica Steri, Juan A. Cámara, Fernando Salangsang, Paul Phojanakong, Melanie McMillan, Victor Gavallos, Andrew D. Leavitt, Aaron C. Logan, Cliona M. Rooney, Justin Eyquem, Andrea Sinz, Benjamin J. Huang, Elliot Stieglitz, Catherine C. Smith, Robert L. Moritz, Sachdev S. Sidhu, Lan Huang, Arun P. Wiita
Publicado 2023Artigo -
12
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome por Alyssa L. Kennedy, Kasiani C. Myers, James R. Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani, Gwen M. Muscato, Robert H. Klein, Kaitlyn Ballotti, Shanshan Liu, Chad E. Harris, Ashley Galvin, Maggie Malsch, David C. Dale, John M. Gansner, Taizo A. Nakano, Alison A. Bertuch, Adrianna Vlachos, Jeffrey M. Lipton, Paul Castillo, James A. Connelly, Jane E. Churpek, John Edwards, Nobuko Hijiya, Richard Ho, Inga Hofmann, James N. Huang, Sioḃán Keel, Adam J. Lamble, Bonnie Lau, Maxim Norkin, Elliot Stieglitz, Wendy Stock, Kelly Walkovich, Steffen Boettcher, Christian Brendel, Mark D. Fleming, Stella M. Davies, Edie Weller, Christopher D. Bahl, Scott L. Carter, Akiko Shimamura, R. Coleman Lindsley
Publicado 2021Artigo -
13
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells por Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik S. Kang, Nikhil Chilakapati, Naomi Akagi, Anveshika Manoj, H. A. Johnson, Tasfia Rashid, Juwita Werner, Abhilash Barpanda, Huimin Geng, Yu-Hsiu T. Lin, Sham Rampersaud, Daniel Gil-Alós, Amin Sobh, Daphné Dupéré-Richer, Adolfo Aleman, Gianina Wicaksono, K.M. Kawehi Kelii, Radhika Dalal, Emilio Ramos, Anjanaa Vijayanarayanan, Kiran Lakhani, Fernando Salangsang, Paul Phojanakong, Juan A. Cámara, Ons Zakraoui, Isa Tariq, Ajai Chari, Alfred Chung, Anupama Deepa Kumar, Thomas G. Martin, Jeffrey L. Wolf, Sandy W. Wong, Veronica Steri, Mala Shanmugam, Lawrence Boise, Tanja Kortemme, Samir Parekh, Elliot Stieglitz, Jonathan D. Licht, William Karlon, Benjamin G. Barwick, Arun P. Wiita
Publicado 2025Artigo -
14
The genomic landscape of juvenile myelomonocytic leukemia por Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang, Laura C Gelston, Yong‐Dong Wang, Tali Mazor, Emilio Esquivel, Ariel Yu, Sara Seepo, Scott R. Olsen, Mara Rosenberg, Sophie Archambeault, Ghada Abusin, Kyle Beckman, Patrick A. Brown, Michael Briones, Benjamin Carcamo, Todd M. Cooper, Gary V. Dahl, Peter D. Emanuel, Mark Fluchel, Rakesh K. Goyal, Robert J. Hayashi, Johann Hitzler, Christopher Hugge, Y. Lucy Liu, Yoav H. Messinger, Donald H. Mahoney, Philip Monteleone, Eneida R. Nemecek, Philip Roehrs, Reuven J. Schore, Kimo C. Stine, Clifford M. Takemoto, Jeffrey A. Toretsky, J Costello, Adam B. Olshen, Chip Stewart, Yongjin Li, Jing Ma, Robert B. Gerbing, Todd A. Alonzo, Gad Getz, Tanja A. Grüber, Todd R. Golub, Kimberly Stegmaier, Mignon L. Loh
Publicado 2015Artigo -
15
Genomic subtyping and therapeutic targeting of acute erythroleukemia por Ilaria Iacobucci, Ji Wen, Manja Meggendorfer, John Choi, Lei Shi, Stanley Pounds, Catherine Carmichael, Katherine E. Masih, Sarah M. Morris, R. Coleman Lindsley, Laura J. Janke, Thomas Alexander, Guangchun Song, Chunxu Qu, Yongjin Li, Debbie Payne-Turner, Daisuke Tomizawa, Nobutaka Kiyokawa, Marcus B. Valentine, Virginia Valentine, Giuseppe Basso, Franco Locatelli, Eric J. Enemark, Shirley Kow Yin Kham, Allen Eng Juh Yeoh, Xiaotu Ma, Xin Zhou, Edgar Sioson, Michael Rusch, Rhonda E. Ries, Elliot Stieglitz, Stephen P. Hunger, Andrew H. Wei, L.B. To, Ian D. Lewis, Richard J. D’Andrea, Benjamin T. Kile, Anna Brown, Hamish S. Scott, Christopher N Hahn, Paula Marlton, Deqing Pei, Cheng Cheng, Mignon L. Loh, Benjamin L. Ebert, Soheil Meshinchi, Torsten Haferlach, Charles G. Mullighan
Publicado 2019Artigo -
16
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium por Yana Pikman, Sarah K. Tasian, Maria Luisa Sulis, Kristen E. Stevenson, Traci M. Blonquist, Beth Apsel Winger, Todd M. Cooper, Melinda Pauly, Kelly W. Maloney, Michael J. Burke, Patrick A. Brown, Nathan Gossai, Jennifer L. McNeer, Neerav Shukla, Peter D. Cole, Justine M. Kahn, Jing Chen, Matthew J. Barth, Jeffrey A. Magee, Lisa Gennarini, Asmani A. Adhav, Catherine Clinton, Nicole Ocasio-Martinez, Giacomo Gotti, Yuting Li, Shan Lin, Alma Imamović, Cristina E. Tognon, Tasleema Patel, Haley L. Faust, Cristina F. Contreras, Anjali Cremer, Wilian A. Cortopassi, Diego Garrido Ruiz, Matthew P. Jacobson, Neekesh V. Dharia, Angela Su, Amanda L. Robichaud, Amy Saur Conway, Katherine Tarlock, Elliot Stieglitz, Andrew E. Place, Alexandre Puissant, Stephen P. Hunger, Annette S. Kim, Neal I. Lindeman, Lia Gore, Katherine A. Janeway, Lewis B. Silverman, Jeffrey W. Tyner, Marian H. Harris, Mignon L. Loh, Kimberly Stegmaier
Publicado 2021Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Genetics
Gene
Medicine
Haematopoiesis
Stem cell
Cancer research
Internal medicine
Leukemia
Oncology
Bioinformatics
Mutation
Immunology
Juvenile myelomonocytic leukemia
Computational biology
Cancer
Myeloid leukemia
Antigen
Bone marrow failure
Chemistry
Chimeric antigen receptor
Clinical trial
Cohort
DNA
DNA methylation
Epigenetics
Gene expression
Germline
Germline mutation
Hematopoietic stem cell transplantation